메뉴 건너뛰기




Volumn 71, Issue 2, 2011, Pages 269-280

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of parkinson's disease

Author keywords

Mptp; Neurodegeneration; Parkinson's disease; Striatum; Substantia nigra

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; TYROSINE 3 MONOOXYGENASE;

EID: 79960097010     PISSN: 00651400     EISSN: 16890035     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (21)

References (101)
  • 1
    • 0025893945 scopus 로고
    • Parkinson's disease: Pathophysiology
    • Agid Y (1991) Parkinson's disease: pathophysiology. Lancet 337:1321-1324.
    • (1991) Lancet , vol.337 , pp. 1321-1324
    • Agid, Y.1
  • 2
    • 0035353725 scopus 로고    scopus 로고
    • Frequency of levodoparelated dyskinesia and motor fluctuations as estimated from the cumulative literature
    • Ahlskog JE, Munenter MD (2001) Frequency of levodoparelated dyskinesia and motor fluctuations as estimated from the cumulative literature. Mov Disord 16: 448-458.
    • (2001) Mov Disord , vol.16 , pp. 448-458
    • Ahlskog, J.E.1    Munenter, M.D.2
  • 5
    • 0031661173 scopus 로고    scopus 로고
    • Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice
    • Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71: 1635-1642.
    • (1998) J Neurochem , vol.71 , pp. 1635-1642
    • Aubin, N.1    Curet, O.2    Deffois, A.3    Carter, C.4
  • 6
    • 0038051345 scopus 로고    scopus 로고
    • Mitochondria, oxidative damage, and inflammation in Parkinson's disease
    • Beal MF (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann NY Acad Sci 991: 120-131.
    • (2003) Ann NY Acad Sci , vol.991 , pp. 120-131
    • Beal, M.F.1
  • 7
    • 0021997074 scopus 로고
    • Poly (ADP-ribose) in the cellular response to DNA damage
    • Berger NA (1985) Poly (ADP-ribose) in the cellular response to DNA damage. Radiat Res 101: 4-15.
    • (1985) Radiat Res , vol.101 , pp. 4-15
    • Berger, N.A.1
  • 8
    • 0034672304 scopus 로고    scopus 로고
    • Towards a neuroprotective gene therapy for Parkinson's disease: Use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
    • Bjorklund S, Bocciardi R, Bonardi G, Matera I, Santamaria G, Mandel RJ (2000) Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res 886: 82-98.
    • (2000) Brain Res , vol.886 , pp. 82-98
    • Bjorklund, S.1    Bocciardi, R.2    Bonardi, G.3    Matera, I.4    Santamaria, G.5    Mandel, R.J.6
  • 9
    • 0034993599 scopus 로고    scopus 로고
    • Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease
    • Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65: 135-172.
    • (2001) Prog Neurobiol , vol.65 , pp. 135-172
    • Blum, D.1    Torch, S.2    Lambeng, N.3    Nissou, M.4    Benabid, A.L.5    Sadoul, R.6    Verna, J.M.7
  • 10
    • 0030938169 scopus 로고    scopus 로고
    • The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-Bcatalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    • Castagnoli K, Palmer S, Anderson A, Bueters T, Castagnoli N Jr (1997) The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-Bcatalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chem Res Toxicol 10: 364-368.
    • (1997) Chem Res Toxicol , vol.10 , pp. 364-368
    • Castagnoli, K.1    Palmer, S.2    Anderson, A.3    Bueters, T.4    Castagnoli Jr., N.5
  • 11
    • 4744369832 scopus 로고    scopus 로고
    • Upregulation of expression and activity guanylyl cyclase in MPTP animals model Parkinson's disease
    • Chalimoniuk M, Langfort J, Lukacova N, Marsala J (2004) Upregulation of expression and activity guanylyl cyclase in MPTP animals model Parkinson's disease. Biochem Biophys Res Commun 324: 118-126.
    • (2004) Biochem Biophys Res Commun , vol.324 , pp. 118-126
    • Chalimoniuk, M.1    Langfort, J.2    Lukacova, N.3    Marsala, J.4
  • 12
    • 33745991786 scopus 로고    scopus 로고
    • Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in mouse
    • Chalimoniuk M, Lukacova N, Marsala J, Langfort J (2006) Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in mouse. Neuroscience 141: 1033-1046.
    • (2006) Neuroscience , vol.141 , pp. 1033-1046
    • Chalimoniuk, M.1    Lukacova, N.2    Marsala, J.3    Langfort, J.4
  • 13
    • 34248201158 scopus 로고    scopus 로고
    • The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice
    • Chalimoniuk M, Langfort J (2007) The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem Int 50: 821-833.
    • (2007) Neurochem Int , vol.50 , pp. 821-833
    • Chalimoniuk, M.1    Langfort, J.2
  • 14
    • 2942642117 scopus 로고    scopus 로고
    • Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetraphdropyridine-treated mice
    • Chen LW, Hu HJ, Liu HL, Yung KK, Chan YS (2004) Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetraphdropyridine-treated mice. Neuroscience 126: 941-953.
    • (2004) Neuroscience , vol.126 , pp. 941-953
    • Chen, L.W.1    Hu, H.J.2    Liu, H.L.3    Yung, K.K.4    Chan, Y.S.5
  • 15
    • 0032563356 scopus 로고    scopus 로고
    • Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced neurotoxicity in C57BL/6 mice
    • Cheng FC, Ni DR, Wu MC, Kuo JS, Chia LG (1998) Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced neurotoxicity in C57BL/6 mice. Neurosci Lett 252: 87-90.
    • (1998) Neurosci Lett , vol.252 , pp. 87-90
    • Cheng, F.C.1    Ni, D.R.2    Wu, M.C.3    Kuo, J.S.4    Chia, L.G.5
  • 16
    • 0030581308 scopus 로고    scopus 로고
    • Poly (ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice
    • Cosi C, Colpaert F, Koek W, Degryse A, Marien M (1996) Poly (ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice. Brain Res 729: 264-269.
    • (1996) Brain Res , vol.729 , pp. 264-269
    • Cosi, C.1    Colpaert, F.2    Koek, W.3    Degryse, A.4    Marien, M.5
  • 17
    • 0032569674 scopus 로고    scopus 로고
    • + and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Prevention by the poly (ADPribose) polymerase inhibitor, benzamide
    • + and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly (ADPribose) polymerase inhibitor, benzamide. Brain Res 809: 58-67.
    • (1998) Brain Res , vol.809 , pp. 58-67
    • Cosi, C.1    Marien, M.2
  • 18
    • 0032514206 scopus 로고    scopus 로고
    • GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice
    • Date I, Aoi M, Tomita S, Collins F, Ohtomo T (1998) GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice. Neuroreport 9: 2365-2369.
    • (1998) Neuroreport , vol.9 , pp. 2365-2369
    • Date, I.1    Aoi, M.2    Tomita, S.3    Collins, F.4    Ohtomo, T.5
  • 19
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
    • (2003) Neuron , vol.39 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 20
    • 0034006478 scopus 로고    scopus 로고
    • Deficiency of inducible nitric oxide synthase protects against MPTP neurotoxicity in vivo
    • Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB (2000) Deficiency of inducible nitric oxide synthase protects against MPTP neurotoxicity in vivo. J Neurochem 74: 2213-2216.
    • (2000) J Neurochem , vol.74 , pp. 2213-2216
    • Dehmer, T.1    Lindenau, J.2    Haid, S.3    Dichgans, J.4    Schulz, J.B.5
  • 21
    • 3042755065 scopus 로고    scopus 로고
    • Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
    • Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F (2004) Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19: 3266-3276.
    • (2004) Eur J Neurosci , vol.19 , pp. 3266-3276
    • Diguet, E.1    Fernagut, P.O.2    Wei, X.3    Du, Y.4    Rouland, R.5    Gross, C.6    Bezard, E.7    Tison, F.8
  • 23
    • 0030832874 scopus 로고    scopus 로고
    • Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase
    • Endres M, Wang Q, Namura S, Waeber C, Moskowitz, MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17: 1143-1151.
    • (1997) J Cereb Blood Flow Metab , vol.17 , pp. 1143-1151
    • Endres, M.1    Wang, Q.2    Namura, S.3    Waeber, C.4    Moskowitz, M.A.5
  • 24
    • 0032555154 scopus 로고    scopus 로고
    • Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
    • Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. PNAS 95: 8880-8885.
    • (1998) PNAS , vol.95 , pp. 8880-8885
    • Endres, M.1    Laufs, U.2    Huang, Z.3    Nakamura, T.4    Huang, P.5    Moskowitz, M.A.6    Liao, J.K.7
  • 26
    • 0028276809 scopus 로고
    • Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinum toxicity to dopaminergic neurons in the rat
    • Frim DM, Uhler TA, Galpem WR, Beal MF, Breakefield XO, Isacson O (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinum toxicity to dopaminergic neurons in the rat. PNAS 9: 5104-5108.
    • (1994) PNAS , vol.9 , pp. 5104-5108
    • Frim, D.M.1    Uhler, T.A.2    Galpem, W.R.3    Beal, M.F.4    Breakefield, X.O.5    Isacson, O.6
  • 27
    • 0005934486 scopus 로고    scopus 로고
    • Neurotrophic factors in neurodegenerative disorders: Model of Parkinson's disease
    • Garcia de Yebenes J, Yebenes J, Mena MA (2000) Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease. Neurotox Res 2: 115-137.
    • (2000) Neurotox Res , vol.2 , pp. 115-137
    • de Garcia Yebenes, J.1    Yebenes, J.2    Mena, M.A.3
  • 29
    • 0024434128 scopus 로고
    • Midbrain dopaminergic cell loss in Parkinson's disease: Computer visualization
    • German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26: 507-514.
    • (1989) Ann Neurol , vol.26 , pp. 507-514
    • German, D.C.1    Manaye, K.2    Smith, W.K.3    Woodward, D.J.4    Saper, C.B.5
  • 31
    • 0028142644 scopus 로고
    • Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl- 4- phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles
    • Gluck MR, Youngster SK, Ramsay RR, Singer TP, Nicklas WJ (1994) Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl- 4- phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles. J Neurochem 63: 655-661.
    • (1994) J Neurochem , vol.63 , pp. 655-661
    • Gluck, M.R.1    Youngster, S.K.2    Ramsay, R.R.3    Singer, T.P.4    Nicklas, W.J.5
  • 33
    • 0343550312 scopus 로고    scopus 로고
    • Apomorphine protects against MPTP-induced neurotoxicity in mice
    • Grunblatt E, Mandel S, Berkuzki T, Youdim MB (1999) Apomorphine protects against MPTP-induced neurotoxicity in mice. Mov Disord 14: 469-481.
    • (1999) Mov Disord , vol.14 , pp. 469-481
    • Grunblatt, E.1    Mandel, S.2    Berkuzki, T.3    Youdim, M.B.4
  • 34
    • 0033598713 scopus 로고    scopus 로고
    • Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
    • Ha HC, Snyder SH (1999) Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. PNAS 96: 13978-13982.
    • (1999) PNAS , vol.96 , pp. 13978-13982
    • Ha, H.C.1    Snyder, S.H.2
  • 35
    • 0025880072 scopus 로고
    • Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine- treated mouse
    • Hadjiconstantinou M, Fitkin JG, Dalia A, Neff NH (1991) Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine- treated mouse. J Neurochem 57: 479-482.
    • (1991) J Neurochem , vol.57 , pp. 479-482
    • Hadjiconstantinou, M.1    Fitkin, J.G.2    Dalia, A.3    Neff, N.H.4
  • 37
    • 0024997609 scopus 로고
    • +) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
    • +) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170: 1049-1055.
    • (1990) Biochem Biophys Res Commun , vol.170 , pp. 1049-1055
    • Hasegawa, E.1    Takeshige, K.2    Oishi, T.3    Murai, Y.4    Minakami, S.5
  • 38
    • 0028239366 scopus 로고
    • Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsiveeffect
    • Hayakawa T, Higuchi Y, Nigami H, Hattori H (1994) Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsiveeffect. Eur J Pharmacol 257: 131-136.
    • (1994) Eur J Pharmacol , vol.257 , pp. 131-136
    • Hayakawa, T.1    Higuchi, Y.2    Nigami, H.3    Hattori, H.4
  • 39
    • 0242384139 scopus 로고    scopus 로고
    • Ethanol effects on neonatal rat cortex: Comparative analyses of neurotrophic factors, apoptosis-related proteins, and oxidative processes during vulnerable and resistant periods
    • Heaton MB, Paiva M, Madorsky I, Shaw G (2003) Ethanol effects on neonatal rat cortex: comparative analyses of neurotrophic factors, apoptosis-related proteins, and oxidative processes during vulnerable and resistant periods. Brain Res Dev Brain Res 145: 249-262.
    • (2003) Brain Res Dev Brain Res , vol.145 , pp. 249-262
    • Heaton, M.B.1    Paiva, M.2    Madorsky, I.3    Shaw, G.4
  • 40
    • 0021280826 scopus 로고
    • Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
    • Heikkila RE, Hess A, Duvoisin RC (1984a) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224: 1451-1453.
    • (1984) Science , vol.224 , pp. 1451-1453
    • Heikkila, R.E.1    Hess, A.2    Duvoisin, R.C.3
  • 41
    • 0021224694 scopus 로고
    • Protection against the dopaminergic neurotox icity of 1-methyl-4-phenyl-1,2,3,6- tetrahydroxypyridine by monoamine oxidase inhibitors
    • Heikkila RE, Manzino L, Cabbat ES, Duvosion RC (1984b) Protection against the dopaminergic neurotox icity of 1-methyl-4-phenyl-1,2,3,6- tetrahydroxypyridine by monoamine oxidase inhibitors. Nature 311: 467-469.
    • (1984) Nature , vol.311 , pp. 467-469
    • Heikkila, R.E.1    Manzino, L.2    Cabbat, E.S.3    Duvosion, R.C.4
  • 42
    • 0031715925 scopus 로고    scopus 로고
    • Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration?
    • Hirsch EC, Hunot S, Damier P, Faucheux B (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol 44: 115-120.
    • (1998) Ann Neurol , vol.44 , pp. 115-120
    • Hirsch, E.C.1    Hunot, S.2    Damier, P.3    Faucheux, B.4
  • 47
    • 2442638936 scopus 로고    scopus 로고
    • Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4- (3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    • Iwashita A, Yamazaki S, Mihara K, Hattori K, Yamamoto H, Ishida J, Matsuoka N, Mutoh S (2004) Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4- (3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Pharmacol Exp Ther 309: 1067-1078.
    • (2004) J Pharmacol Exp Ther , vol.309 , pp. 1067-1078
    • Iwashita, A.1    Yamazaki, S.2    Mihara, K.3    Hattori, K.4    Yamamoto, H.5    Ishida, J.6    Matsuoka, N.7    Mutoh, S.8
  • 48
    • 0026342172 scopus 로고
    • Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites
    • Johannessen JN, Sobotka TJ, Weise VK, Markey SP (1991) Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites. J Neurochem 57: 981-990.
    • (1991) J Neurochem , vol.57 , pp. 981-990
    • Johannessen, J.N.1    Sobotka, T.J.2    Weise, V.K.3    Markey, S.P.4
  • 49
    • 0033456249 scopus 로고    scopus 로고
    • Etodolac: An overview of a selective COX-2 inhibitor
    • Jones RA (1999) Etodolac: An overview of a selective COX-2 inhibitor. Inflammopharmacology 7:269-275.
    • (1999) Inflammopharmacology , vol.7 , pp. 269-275
    • Jones, R.A.1
  • 50
    • 61549143699 scopus 로고    scopus 로고
    • Age- and sexdifferences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine
    • Joniec I, Ciesielska A, Kurkowska I, Przybylkowski A, Czlonkowska A, Czlonkowski A (2009) Age- and sexdifferences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine. Brain Res 1261: 1362-1367.
    • (2009) Brain Res , vol.1261 , pp. 1362-1367
    • Joniec, I.1    Ciesielska, A.2    Kurkowska, I.3    Przybylkowski, A.4    Czlonkowska, A.5    Czlonkowski, A.6
  • 51
    • 3042654997 scopus 로고    scopus 로고
    • Does cellular iron dysregulation play a causative role in Parkinson's disease?
    • Kauer D, Andersen J (2004) Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev 3: 327-343.
    • (2004) Ageing Res Rev , vol.3 , pp. 327-343
    • Kauer, D.1    Andersen, J.2
  • 53
    • 77954085675 scopus 로고    scopus 로고
    • Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease
    • Kuroiwa H, Yokoyama H, Kimoto H, Kato H, Araki T (2010) Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease. Metab Brain Dis 25: 177-183.
    • (2010) Metab Brain Dis , vol.25 , pp. 177-183
    • Kuroiwa, H.1    Yokoyama, H.2    Kimoto, H.3    Kato, H.4    Araki, T.5
  • 54
    • 33846641782 scopus 로고    scopus 로고
    • Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: Fenofibrate has a neuroprotective effect, whereas benzafibrate and HMG-CoA reductase inhibitors do not
    • Kreisler A, Gele P, Wiart JF, Lhermitte M, Destee A, Bordet R (2007) Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: Fenofibrate has a neuroprotective effect, whereas benzafibrate and HMG-CoA reductase inhibitors do not. Brain Res 1135: 77-84.
    • (2007) Brain Res , vol.1135 , pp. 77-84
    • Kreisler, A.1    Gele, P.2    Wiart, J.F.3    Lhermitte, M.4    Destee, A.5    Bordet, R.6
  • 55
    • 0030864433 scopus 로고    scopus 로고
    • Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
    • Lan J, Jiang DH (1997) Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J Neural Transm 104: 469-481.
    • (1997) J Neural Transm , vol.104 , pp. 469-481
    • Lan, J.1    Jiang, D.H.2
  • 57
    • 0020680904 scopus 로고
    • Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis
    • Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis. Science 219: 979-980.
    • (1983) Science , vol.219 , pp. 979-980
    • Langston, J.W.1    Ballard, P.2    Tetrud, J.W.3    Irwin, I.4
  • 58
    • 0021337873 scopus 로고
    • Selective nigral toxicity after systemic administration of 1-methyl- 4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
    • Langston JW, Forno LS, Rebert CS, Irwin I (1984) Selective nigral toxicity after systemic administration of 1-methyl- 4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res 292: 390-394.
    • (1984) Brain Res , vol.292 , pp. 390-394
    • Langston, J.W.1    Forno, L.S.2    Rebert, C.S.3    Irwin, I.4
  • 60
    • 33750347347 scopus 로고    scopus 로고
    • Mitochondrial dysfunction and oxidative stress in neurodegenerative disease
    • Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative disease. Nature 443: 787-795.
    • (2006) Nature , vol.443 , pp. 787-795
    • Lin, M.T.1    Beal, M.F.2
  • 61
    • 0035983408 scopus 로고    scopus 로고
    • Parametric mapping of [18F]FPCT binding in early stage Parkinson's disease: A PET study
    • Ma Y, Dhawan V, Mentis M, Chaly T, Spetsiers PG, Eidelberg D (2002) Parametric mapping of [18F]FPCT binding in early stage Parkinson's disease: a PET study. Synapse 45: 125-133.
    • (2002) Synapse , vol.45 , pp. 125-133
    • Ma, Y.1    Dhawan, V.2    Mentis, M.3    Chaly, T.4    Spetsiers, P.G.5    Eidelberg, D.6
  • 62
    • 0023789193 scopus 로고
    • Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's disease and Alzheimer's disease brains
    • MacGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's disease and Alzheimer's disease brains. Neurology 38: 1285-1291.
    • (1988) Neurology , vol.38 , pp. 1285-1291
    • Macgeer, P.L.1    Itagaki, S.2    Boyes, B.E.3    McGeer, E.G.4
  • 64
    • 0021137683 scopus 로고
    • Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
    • Markey SP, Johannessen JN, Chiueh CC, Burns RS, Herkenham MA (1984) Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311: 464-467.
    • (1984) Nature , vol.311 , pp. 464-467
    • Markey, S.P.1    Johannessen, J.N.2    Chiueh, C.C.3    Burns, R.S.4    Herkenham, M.A.5
  • 68
    • 1442276965 scopus 로고    scopus 로고
    • Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease
    • Murata M (2004) Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease. Curr Pharm Des 10: 687-693.
    • (2004) Curr Pharm Des , vol.10 , pp. 687-693
    • Murata, M.1
  • 69
    • 33846054367 scopus 로고    scopus 로고
    • Zonisamide improves motor function in Parkinson's disease: A randomized, double-blind study
    • Murata M, Hasegawa K, Kanazawa I (2007) Zonisamide improves motor function in Parkinson's disease: a randomized, double-blind study. Neurology 68: 45-50.
    • (2007) Neurology , vol.68 , pp. 45-50
    • Murata, M.1    Hasegawa, K.2    Kanazawa, I.3
  • 70
    • 0034525420 scopus 로고    scopus 로고
    • Changes in cytokines and neurotrophins in Parkinson's disease
    • Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm 60: 277-290.
    • (2000) J Neural Transm , vol.60 , pp. 277-290
    • Nagatsu, T.1    Mogi, M.2    Ichinose, H.3    Togari, A.4
  • 71
    • 0035914209 scopus 로고    scopus 로고
    • GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons
    • Nakajima K, Hida H, Shimano Y, Fujimoto I, Hashitani T, Kumazaki M, Sakurai T, Nishino H (2001) GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res 916: 76-84.
    • (2001) Brain Res , vol.916 , pp. 76-84
    • Nakajima, K.1    Hida, H.2    Shimano, Y.3    Fujimoto, I.4    Hashitani, T.5    Kumazaki, M.6    Sakurai, T.7    Nishino, H.8
  • 72
    • 26444465185 scopus 로고    scopus 로고
    • L-DOPA treatment from the viewpoint of neuroprotection: Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease
    • Ogawa N, Asanuma M, Miyazaki I, Diaz-Corrales F, Miyoshi K (2005) L-DOPA treatment from the viewpoint of neuroprotection: possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease. J Neurol 252: iv23-iv31.
    • (2005) J Neurol , vol.252
    • Ogawa, N.1    Asanuma, M.2    Miyazaki, I.3    Diaz-Corrales, F.4    Miyoshi, K.5
  • 73
    • 0028430953 scopus 로고
    • FGF-2 in the MPTP model of Parkinson's disease: Effects on astroglial cells
    • Otto D, Unsicker K (1994) FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells. Glia 11: 47-56.
    • (1994) Glia , vol.11 , pp. 47-56
    • Otto, D.1    Unsicker, K.2
  • 75
    • 0029984860 scopus 로고    scopus 로고
    • Role of neuronal nitric oxide in 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
    • Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. PNAS 93: 4565-4571.
    • (1996) PNAS , vol.93 , pp. 4565-4571
    • Przedborski, S.1    Jackson-Lewis, V.2    Yokoyama, R.3    Shibata, T.4    Dawson, V.L.5    Dawson, T.M.6
  • 77
    • 0023141542 scopus 로고
    • Aging and 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra
    • Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW (1987) Aging and 1-methyl-4-phenyl-1-,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res 403: 43-51.
    • (1987) Brain Res , vol.403 , pp. 43-51
    • Ricaurte, G.A.1    Irwin, I.2    Forno, L.S.3    Delanney, L.E.4    Langston, E.5    Langston, J.W.6
  • 78
    • 0024593140 scopus 로고
    • Blockade of sustained repetitive action potentials in cultured spin al cord neurons by zonisaimde (AD 810, CI 912), a novel anticonvulsant
    • Rock D, MacDonald R, Taylor C (1989) Blockade of sustained repetitive action potentials in cultured spin al cord neurons by zonisaimde (AD 810, CI 912), a novel anticonvulsant. Epilepsy Res 3: 138-143.
    • (1989) Epilepsy Res , vol.3 , pp. 138-143
    • Rock, D.1    Macdonald, R.2    Taylor, C.3
  • 79
    • 0033811469 scopus 로고    scopus 로고
    • Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia
    • Schäbitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S (2000) Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke 31: 2212-2217.
    • (2000) Stroke , vol.31 , pp. 2212-2217
    • Schäbitz, W.R.1    Sommer, C.2    Zoder, W.3    Kiessling, M.4    Schwaninger, M.5    Schwab, S.6
  • 80
    • 0023186374 scopus 로고
    • Zonisamide enhances slow sodium inactivation in Myxicola
    • Schauf C (1987) Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res 413: 185-188.
    • (1987) Brain Res , vol.413 , pp. 185-188
    • Schauf, C.1
  • 81
    • 0028796770 scopus 로고
    • Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice
    • Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64: 936-939.
    • (1995) J Neurochem , vol.64 , pp. 936-939
    • Schulz, J.B.1    Matthews, R.T.2    Muqit, M.M.3    Browne, S.E.4    Beal, M.F.5
  • 82
    • 0031978372 scopus 로고    scopus 로고
    • Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: Selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway
    • Skaper SD, Floreani M, Negro A, Facci L, Giusti P (1996) Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J Neurochem 70: 1859-1868.
    • (1996) J Neurochem , vol.70 , pp. 1859-1868
    • Skaper, S.D.1    Floreani, M.2    Negro, A.3    Facci, L.4    Giusti, P.5
  • 83
    • 0026689954 scopus 로고
    • Brain-derived neuotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methy-4-phenylpyridinum ion toxicity: Involvement of the glutathione system
    • Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neuotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methy-4-phenylpyridinum ion toxicity: involvement of the glutathione system. J Neurochem 59: 99-106.
    • (1992) J Neurochem , vol.59 , pp. 99-106
    • Spina, M.B.1    Squinto, S.P.2    Miller, J.3    Lindsay, R.M.4    Hyman, C.5
  • 84
    • 0031036391 scopus 로고    scopus 로고
    • Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice
    • Sriram K, Pai KS, Boyd MR, Ravindranath V (1997) Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice. Brain Res 749: 44-52.
    • (1997) Brain Res , vol.749 , pp. 44-52
    • Sriram, K.1    Pai, K.S.2    Boyd, M.R.3    Ravindranath, V.4
  • 85
    • 33645123006 scopus 로고    scopus 로고
    • Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: Role of tumor necrosis factor
    • Sriram K, Miller DB, O'Callaghan P (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor. J Neurochem 96: 706-718.
    • (2006) J Neurochem , vol.96 , pp. 706-718
    • Sriram, K.1    Miller, D.B.2    O'Callaghan, P.3
  • 87
    • 0032127666 scopus 로고    scopus 로고
    • Role of poly (ADP-ribose) synthetase in inflammation and ischemia-reperfusion
    • Szabo C, Dawson W (1998) Role of poly (ADP-ribose) synthetase in inflammation and ischemia-reperfusion. Trends Pharmacol Sci 19: 287-298.
    • (1998) Trends Pharmacol Sci , vol.19 , pp. 287-298
    • Szabo, C.1    Dawson, W.2
  • 88
    • 0035876916 scopus 로고    scopus 로고
    • Minocycline provides neuroprotection against N-methyl-D-aspirate neurotoxicity by inhibiting microglia
    • Tikka TM, Koistinaho JE (2001) Minocycline provides neuroprotection against N-methyl-D-aspirate neurotoxicity by inhibiting microglia. J Immunol 166: 7527-7533.
    • (2001) J Immunol , vol.166 , pp. 7527-7533
    • Tikka, T.M.1    Koistinaho, J.E.2
  • 89
    • 0027504297 scopus 로고
    • Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds
    • Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61: 1191-1206.
    • (1993) J Neurochem , vol.61 , pp. 1191-1206
    • Tipton, K.F.1    Singer, T.P.2
  • 91
    • 0029103262 scopus 로고
    • Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine- induced parkinsonism in monkeys
    • Tsukahara T, Takeda M, Shimohama S, Ohara O, Hashimoto N (1995) Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine- induced parkinsonism in monkeys. Neurosurgery 37: 733-739.
    • (1995) Neurosurgery , vol.37 , pp. 733-739
    • Tsukahara, T.1    Takeda, M.2    Shimohama, S.3    Ohara, O.4    Hashimoto, N.5
  • 92
    • 0037713529 scopus 로고    scopus 로고
    • Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease
    • Wang H, Shimoj M, Yu SW, Dawson TM, Dawson VL (2003) Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann NY Acad Sci 991: 132-139.
    • (2003) Ann NY Acad Sci , vol.991 , pp. 132-139
    • Wang, H.1    Shimoj, M.2    Yu, S.W.3    Dawson, T.M.4    Dawson, V.L.5
  • 93
    • 0028292964 scopus 로고
    • Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions
    • Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268: 1597-1604.
    • (1994) J Pharmacol Exp Ther , vol.268 , pp. 1597-1604
    • Watanabe, T.1    Yuki, S.2    Egawa, M.3    Nishi, H.4
  • 96
    • 74149085603 scopus 로고    scopus 로고
    • A novel anti-parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice
    • Yano R, Yokoyama H, Kuroiwa H, Kato H, Araki T (2009) A novel anti-parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice. J Mol Neurosci 39: 211-219.
    • (2009) J Mol Neurosci , vol.39 , pp. 211-219
    • Yano, R.1    Yokoyama, H.2    Kuroiwa, H.3    Kato, H.4    Araki, T.5
  • 97
    • 44949242548 scopus 로고    scopus 로고
    • Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice
    • Yokoyama H, Takagi S, Watanabe Y, Kato H, Araki T (2008) Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. J Neural Transm 115: 831-842.
    • (2008) J Neural Transm , vol.115 , pp. 831-842
    • Yokoyama, H.1    Takagi, S.2    Watanabe, Y.3    Kato, H.4    Araki, T.5
  • 98
    • 77952038836 scopus 로고    scopus 로고
    • Poly (ADP-ribose) polymerase (PARP) nhibitor can attenuate the neuronal death after MPTP-induced neurotoxicity in mice
    • Yokoyama H, Kuroiwa H, Tsukada T, Uchida H, Kato H, Araki T (2010a) Poly (ADP-ribose) polymerase (PARP) nhibitor can attenuate the neuronal death after MPTP-induced neurotoxicity in mice. J Neurosci Res 88: 1522-1536.
    • (2010) J Neurosci Res , vol.88 , pp. 1522-1536
    • Yokoyama, H.1    Kuroiwa, H.2    Tsukada, T.3    Uchida, H.4    Kato, H.5    Araki, T.6
  • 99
    • 77954089281 scopus 로고    scopus 로고
    • Therapeutic effect of a novel ant-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice
    • Yokoyama H, Yano R, Kuroiwa H, Tsukada T, Uchida H, Kato H, Kasahara J, Araki T (2010b) Therapeutic effect of a novel ant-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Metab Brain Dis 25: 135-143.
    • (2010) Metab Brain Dis , vol.25 , pp. 135-143
    • Yokoyama, H.1    Yano, R.2    Kuroiwa, H.3    Tsukada, T.4    Uchida, H.5    Kato, H.6    Kasahara, J.7    Araki, T.8
  • 101
    • 0028294246 scopus 로고
    • Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity
    • Zhang J, Dawson VL, Dawson TM, Snyder SH (1994) Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689.
    • (1994) Science , vol.263 , pp. 687-689
    • Zhang, J.1    Dawson, V.L.2    Dawson, T.M.3    Snyder, S.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.